ArticleMolecular biology reports2025
Identification of a missing Pictet-Spenglerase in the Gloriosa superba L. colchicine biosynthesis pathway.
Article in Molecular biology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Structural and functional insights into the iminium ion intermediate in AsKslB-mediated Pictet-Spengler reaction.Synthetic and systems biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundColchicine is a natural medicinal alkaloid from Gloriosa superba L. The biosynthetic pathway of colchicine has been nearly completely revealed, but the Pictet-Spenglerase that catalyses the formation of the crucial intermediate 1-phenethylisoquinoline scaffold has not been identified. Identification and characterization of the missing Pictet-Spenglerase will provide the last piece of the puzzle of colchicine biosynthesis in G. superba.
resultsBased on the G. superba transcriptome database, orthologues of 1-phenethylisoquinoline scaffold synthase (PSS) were identified and screened, and one candidate gene sequence, GsPSS, was identified. GsPSS has a total length of 480 bp, and multisequence alignment revealed that GsPSS had two common conserved catalytic residues. The subcellular results indicated that GsPSS was localized in the cytoplasm. After heterologous expression in E. coli and purification, in vitro enzyme assays indicated that the recombinant GsPSS protein could catalyse the conversion of 3-(4-Hydroxyphenyl) propanal (4-HDCA) and dopamine to generate a 1-phenethylisoquinoline scaffold.
conclusionIn this study, we identified the last previously unknown enzyme involved in the biosynthesis of colchicine. This enzyme belongs to the Pr10/Bet v1 family and catalyses the committed step in colchicine biosynthesis. The knowledge gained here will help to complement and improve the colchicine biosynthetic pathway and facilitate the biosynthesis of colchicine via metabolic engineering.
Indexed as
Identifiers
39964647What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.